Qms Medical Allied Services Ltd vs Yatharth Hospital Trauma Care Services Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of QMS Medical Allied Services Ltd is ₹ 181.17 as of 30 Oct 15:30 . The P/E Ratio of QMS Medical Allied Services Ltd changed from 23.2 on March 2024 to 0 on March 2023 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Yatharth Hospital & Trauma Care Services Ltd changed from 31.3 on March 2024 to 0 on March 2023 . This represents a CAGR of -100.00% over 6 years The Market Cap of QMS Medical Allied Services Ltd changed from ₹ 208.93 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Yatharth Hospital & Trauma Care Services Ltd changed from ₹ 3582 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 6 years The revenue of QMS Medical Allied Services Ltd for the Jun '26 is ₹ 57.28 crore as compare to the Mar '26 revenue of ₹ 44.65 crore. This represent the growth of 28.29% The revenue of Yatharth Hospital & Trauma Care Services Ltd for the Jun '26 is ₹ 397.01 crore as compare to the Mar '26 revenue of ₹ 348.67 crore. This represent the growth of 13.86% The ebitda of QMS Medical Allied Services Ltd for the Jun '26 is ₹ 8.73 crore as compare to the Mar '26 ebitda of ₹ 6.13 crore. This represent the growth of 42.41% The ebitda of Yatharth Hospital & Trauma Care Services Ltd for the Jun '26 is ₹ 96.04 crore as compare to the Mar '26 ebitda of ₹ 87.02 crore. This represent the growth of 10.37% The net profit of QMS Medical Allied Services Ltd changed from ₹ 2.4 crore to ₹ 3.96 crore over 9 quarters. This represents a CAGR of 24.93% The net profit of Yatharth Hospital & Trauma Care Services Ltd changed from ₹ 30.38 crore to ₹ 45.42 crore over 9 quarters. This represents a CAGR of 19.57% The Dividend Payout of QMS Medical Allied Services Ltd changed from 9.92 % on March 2024 to 144.54 % on March 2026 . This represents a CAGR of 144.24% over 3 yearsThe Dividend Payout of Yatharth Hospital & Trauma Care Services Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About QMS Medical Allied Services Ltd

QMS Medical Allied Services Limited was incorporated as 'QMS Medical Allied Services Private Limited' on September 14, 2017.
The status of the Company was changed to Public Limited and name of the Company changed to QMS Medical Allied Services Limited on October 22, 2020.
The Company is engaged in marketing, trading and distribution of a wide range of Medical Products, Medical and Surgical Instruments, Medical Equipments & Accessories and Medical Devices. Presently, the Company manage a wide range portfolio of products sold under brand 'Qdevices' and also distribution for other brands such as 3M, Heine, Rossmax etc.
Further, it organizes and provides medical education to members belonging to medical fraternity like, physicians, nurses, nurse practitioners, physician assistants, pharmacists, and other healthcare professionals by partnering with renowned medical education institutions such as EACME.

About Yatharth Hospital & Trauma Care Services Ltd

Yatharth Hospital & Trauma Care Services Limited was formerly incorporated as a Private Limited Company in Delhi dated February 28, 2008.
On November 3, 2021, the status converted into a Public Company and name of the Company was changed to Yatharth Hospital & Trauma Care Services Limited' on November 18, 2021 issued by the RoC. Yatharth Hospitals and Trauma Care Services Limited is a network of super speciality hospitals across Delhi National Capital Region (NCR) and Madhya Pradesh, capitalising on the robust healthcare infrastructure in these regions to serve a wide patient base in need of tertiary care. The Company operate three super specialty hospitals in Delhi NCR, i.e., at Greater Noida, Uttar Pradesh.
The super speciality tertiary care hospital currently operates with 400 beds, including 112 critical care beds and 9 modular operation theatres, among other surgical facilities.

FAQs for the comparison of QMS Medical Allied Services Ltd and Yatharth Hospital & Trauma Care Services Ltd

Which company has a larger market capitalization, QMS Medical Allied Services Ltd or Yatharth Hospital & Trauma Care Services Ltd?

Market cap of QMS Medical Allied Services Ltd is 350 Cr while Market cap of Yatharth Hospital & Trauma Care Services Ltd is 8,942 Cr

What are the key factors driving the stock performance of QMS Medical Allied Services Ltd and Yatharth Hospital & Trauma Care Services Ltd?

The stock performance of QMS Medical Allied Services Ltd and Yatharth Hospital & Trauma Care Services Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for QMS Medical Allied Services Ltd and Yatharth Hospital & Trauma Care Services Ltd?

As of November 1, 2026, the QMS Medical Allied Services Ltd stock price is INR ₹181.17. On the other hand, Yatharth Hospital & Trauma Care Services Ltd stock price is INR ₹928.05.

How do dividend payouts of QMS Medical Allied Services Ltd and Yatharth Hospital & Trauma Care Services Ltd compare?

To compare the dividend payouts of QMS Medical Allied Services Ltd and Yatharth Hospital & Trauma Care Services Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.